Osteonectin promotes prostate cancer cell migration and invasion: A possible mechanism for metastasis to bone

Cancer Research

Volumn 59, Issue 17, 1999, Pages 4453-4457

  Jacob, Karin ^a   Webber, Mukta ^b   Benayahu, Dafna ^c   Kleinman, Hynda K ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX METALLOPROTEINASE; OSTEONECTIN;

ARTICLE; BONE METASTASIS; CANCER INVASION; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER;

BONE AND BONES; BONE NEOPLASMS; CELL DIVISION; CELL MOVEMENT; CHEMOTACTIC FACTORS; HUMANS; MALE; METALLOENDOPEPTIDASES; NEOPLASM INVASIVENESS; OSTEONECTIN; PROSTATIC NEOPLASMS; TISSUE EXTRACTS; TUMOR CELLS, CULTURED;

EID: 0033199111     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Mettlin, C., Jones, G. W., and Murphy G. P. Trends in prostate cancer care in the United States, 1974-1990: observations from the patient care evaluation studies of the American College of Surgeons Commission on Cancer. CA Cancer J. Clin., 43: 83-91, 1993.
2. Orr, F. W., Sanchez-Sweatman, O. H., Kostenuik, P., and Singh, G. Tumor-bone interactions in skeletal metastasis. Clin. Orthop., 312: 19-33, 1995.
3. Mundy.G. R. Mechansims of bone metastasis. Cancer (Phila.), 80: 1546-1556, 1997.
4. Scalliet, P. Carcinoma of the prostate: treatment of bone metastasis. Acta Urol. Belg., 64: 87-90, 1994.
5. Carter, H. B., and Coffey, D. S. The prostate: an increasing medical problem. Prostate, 16: 39-48, 1990.
6. Saitoh, H., Hida, M., Shimbo, T., Nakamura, K., Yamagata, J., and Satah, T. Metastatic patterns of prostatic cancer. Correlation between sites and number of organs involved. Cancer (Phila.), 54: 3078-3084, 1984.
7. Resnick, M. I. Hemodynamics of prostate cancer bone metastases. Adv. Exp. Med. Biol., 324: 77-81, 1992.
8. Paget, S. The distribution of secondary growth in cancer of the breast. Lancet, 1:: 571-573, 1889.
9. Hart, I. R. 'Seed, and soil' revisited: mechanisms of site-specific metastasis. Cancer Metastasis Rev., 1: 5-16, 1982.
10. Haq, M., Goltzmann, D., Tremblay, G., and Brodt, P. Rat prostate adenocarcinoma cells disseminate to bone and adhere preferentially to bone marrow-derived endothelial cells. Cancer Res., 52: 4613-4619, 1992.
11. Lehr, J. E., and Pienta, K. J. Preferential adhesion of prostate cancer cells to a human bone marrow endothelial cell line. J. Natl. Cancer lnst., 90: 118-123, 1998.
12. Lang, S. H., Miller, W. R., and Habib, F. K. Stimulation of human prostate cancer cell lines by factors present in human osteoblast-like cells but not in bone marrow. Prostate, 27: 287-293, 1995.
13. Webber, M. M., Bello, D., Kleinman, H. K., Wartinger, D. D., Williams, D. E., and Rhim J. S. Prostate specific antigen and androgen receptor induction and characterization of an immortalized adult human prostatic epithelial cell line. Carcinogenesis (Lond.), 17: 1641-1646, 1996.
14. Bello, D., Webber, M. M., Kleinman, H. K., Wartinger, D. D., and Rhim J. S. Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. Carcinogenesis (Lond.), 18: 1215-1223, 1997.
15. Hujanen, E. S., and Terranova, V. P. Migration of tumor cells to organ-derived chemoattractants. Cancer Res., 45: 3517-3521, 1985.
16. Albini, A., Iwamato, Y., Kleinman, H. K., Martin, G. W., Aaronson, S. A., Kozlowski, J. M., and McEwan, R. N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res., 47: 3239-3245, 1987.
17. Kleinman, H. K., McGarvey, M. L., Hassell, J. R., Star, V. L., Cannon, F. B., Laurie, G. W., and Martin G. R. Basement membrane complexes with biological activity. Biochemistry, 25: 312-318, 1986.
18. Woodhouse, E. C., Chuaqui, R. F., and Liotta L. A. General mechanisms of metastasis. Cancer (Phila.) 80 (Suppl.): 1529-1537, 1997.
19. Liotta, L. A., Rao, C. N., and Barsky S. H. Tumor invasion and the extracellular matrix. Lab. Invest., 49: 636-649, 1983.
20. Nicolson, G. L. Cancer metastasis. Organ colonization and the cell-surface properties of malignant cells. Biochim. Biophys. Acta, 695: 113-176, 1982.
21. Nicolson, G. L. Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer Metastasis Rev., 7: 143-188, 1988.
22. Poste, G., and Fidler I. J. The pathogenesis of cancer metastasis. Nature (Lond.), 283: 139-146, 1980.
23. Massova, I., Kotra, L. R., Fridman R., and Mobashery, S. Matrix metalloproteinases: structures, evolution, and diversification. FASEB J., 273: 10672-10681, 1998.
24. Gilles, C., Bassuk, J. A., Pulyaeva, H., Sage, H. E., Foidart, J. M., and Thompson, E. W. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines. Cancer Res., 58: 5529-5536, 1998.
25. Termine, J. D., Kleinman, H. K., Whitson, S. W., Conn, K. M., McGarvey, M. L., and Martin, G. R. Osteonectin, a bone-specific protein linking mineral to collagen. Cell, 26: 99-105, 1981.
26. Sage, H., Johnson, C., and Bomstein, P. Characterization of a novel serum albumin-binding glycoprotein secreted by endothelial cells in culture. J. Biol. Chem., 259: 3993-4007, 1984.
27. Dziadek, M., Paulsson, M., Aumailley, M., and Timpl, R. Purification and tissue distribution of a small protein (BM-40) extracted from a basement membrane tumor. Eur. J. Biochem., 161: 455-464, 1986.
28. Nomura, S., Wills, A., J., Edwards, D. R., Heath, J. K., and Hogan, B. L. M. Developmental expression of 2ar (osteopontin) and SPARC (osleonectin) RNA as revealed by in situ hybridization. J. Cell Biol., 106: 441-450, 1988.
29. Metsaranta, M., Young, M. F., Sandberg, M., Termine, J., and Vuorio, E. Localization of osteonectin expression in human fetal skeletal tissues by in situ hybridization. Calcif. Tissue Int., 45: 146-152, 1989.
30. Wewer, U. M., Albrechtsen, R., Fisher L. W., Young, M. F., and Termine, J. D. Osteonectin/SPARC/BM-40 in human decidua and carcinoma, tissues characterized by de novo formation of basement membrane. J. Pathol., 132: 345-355, 1988.
31. Schulz, A.. Jundt, G., Berghauser K. H., Gehron-Robey, P., and Termine J. D. Immunohistochemical study of osteonectin in various types of osteosarcoma. Am. J. Pathol., 132: 233-238, 1988.
32. Lane, T. F., and Sage, E. H. The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J., 2: 163-173, 1994.
33. Ledda, M. F., Adris, S., Bravo A. I., Kairiyama, C., Bover, L., Chernajovsky, Y., Mordoh, J., and Podhajcer, O. L. Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells. Nat. Med., 2: 171-176, 1997.
34. Shankavaram, U. T., DeWitt, D. L., Funk S. E., Sage, E. H., and Wahl, L. M. Regulation of human monocyte matrix metalloproteinases by SPARC. J. Cell. Physiol., 173: 327-334, 1997.
35. Kelm, R. J., and Mann, K. G. The collagen binding specificity of bone and platelet osteonectin is related to differences in glycosylation. J. Biol. Chem., 25: 9632-9639, 1991.
36. Tracy, R. P., Shull, S., Riggs, L., and Mann K. G. The osteonectin family of proteins. Int. J. Biochem., 20: 653-660, 1988.
37. Girard, J. P., and Springer, T. A. Cloning from purified high endothelial venule cells of hevin, a close relative of the antiadhesive extracellular matrix protein SPARC. Immunity, 1: 113-123, 1995.
38. Johnston, I. G., Paladino, T., Gurd, J. W., and Brown, I. R. Molecular cloning of SC1: a putative brain extracellular matrix glycoprotein showing partial similarity to osteonectin/BM40/SPARC. Neuron, 4: 165-176, 1990.